Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Other Working Capital Changes (2024 - 2025)

Historic Other Working Capital Changes for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to -$195365.0.

  • Neuphoria Therapeutics' Other Working Capital Changes rose 812.36% to -$195365.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$741370.0, marking a year-over-year change of. This contributed to the annual value of -$468427.0 for FY2025, which is 3829.61% down from last year.
  • Per Neuphoria Therapeutics' latest filing, its Other Working Capital Changes stood at -$195365.0 for Q4 2025, which was up 812.36% from -$517874.0 recorded in Q3 2025.
  • In the past 5 years, Neuphoria Therapeutics' Other Working Capital Changes ranged from a high of $2428.0 in Q1 2025 and a low of -$517874.0 during Q3 2025